LMRI Lumexa Imaging Holdings, Inc. Insider Trading

Director Brett Brodnax bought 35,000 shares of LMRI at $7.25 on 2026-05-19, raising holdings to 62,027 shares (+129.5% vs pre-transaction).

Brett Brodnax purchased 35,000 shares at $7.25 on 2026-05-19, substantially doubling his position from 27,027 shares to 62,027 shares. The transaction occurred when the stock was trading well below its 52-week high of $19.45 (currently -57.9% from peak) and has declined 43.8% over the prior 90 days, creating a backdrop of significant price weakness. The company generated $252.5M in revenue with $1.7M net income in the latest quarter and maintains a $785.9M market cap. However, the absence of FLAGS in this filing indicates this was a discretionary open-market purchase by a director during a period of material stock decline, yet the narrative must remain factual without attributing strategic intent based solely on timing or price context.

Director Cooper Henry Lee buys 30,000 shares of LMRI at $7.44; stock down -65.2% from 52-week high of $19.45

Cooper Henry Lee purchased 30,000 shares at $7.44 on 2026-05-14, representing his first position in LMRI. The purchase occurs against a backdrop of significant price deterioration: the stock trades at $6.77, down 29.9% over 30 days and 55.5% over 90 days, positioned -65.2% below its 52-week high of $19.45. The company maintains substantial scale with $252.5M in quarterly revenue and a $650.5M market cap, though recent profitability shows $1.7M net income. This transaction establishes a new director holding but provides limited context regarding directional intent given the absence of prior trading pattern at this ticker.